Impact Capital Partners »

Myriad Genetics shares owned by Impact Capital Partners

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Impact Capital Partners from 13F filings

Historical chart of Impact Capital Partners investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Impact Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Impact Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $102k 18k 5.71

More positions owned by Impact Capital Partners

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Wisdomtree Tr Dynamic Intl Eqt (DDWM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Procter & Gamble Company (PG)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Amazon (AMZN)
Ishares Tr Msci Intl Moment (IMTM)
Abbvie (ABBV)
Ishares Tr Core Us Aggbd Et (AGG)
Analog Devices (ADI)

View all positions for Impact Capital Partners

Top funds holding Myriad Genetics

BlackRock
Millennium Management
Vestal Point Capital
D. E. Shaw & Co
State Street Corporation
Vanguard Capital Management
Morgan Stanley
Acadian Asset Management
Vanguard Portfolio Management
AQR Capital Management
Geode Capital Management
Goldman Sachs Group
Jacobs Levy Equity Management
Charles Schwab Investment Management
Sixth Street Partners Management Company

View all funds holding Myriad Genetics